Margaret Ferris

Medicine & Life Sciences

1. Acute Myeloid Leukemia 100%
2. Myeloid Cells 45%
3. Mutation 42%
4. Nuclear Receptor Subfamily 4, Group A, Member 1 40%
5. Ligands 40%
6. Clonal Evolution 33%
7. Somites 31%
8. Cellular Microenvironment 29%
9. Bexarotene 28%
10. Genetic Heterogeneity 28%
11. Whole Genome Sequencing 27%
12. Clone Cells 27%
13. Retinoids 26%
14. Induced Pluripotent Stem Cells 26%
15. Methyltransferases 26%
16. Periodicity 26%
17. Leukemia 25%
18. Morphogenesis 23%
19. Cell Communication 22%
20. Drosophila 22%
21. Proteomics 21%
22. Transcriptional Activation 21%
23. Retinoid X Receptors 21%
24. Epigenomics 20%
25. Mesoderm 17%
26. Genes 15%
27. Gastrulation 15%
28. Cytokines 14%
29. Genome 13%
30. Recurrence 13%
31. Proteins 13%
32. Acute Promyelocytic Leukemia 11%
33. Interleukin-3 11%
34. Granulocyte Colony-Stimulating Factor 10%
35. Embryonic Structures 9%
36. Phenotype 9%
37. Ubiquitin-Protein Ligases 9%
38. Enzymes 8%
39. Proteasome Endopeptidase Complex 8%
40. Karyotype 8%
41. Nucleotides 7%
42. Phosphotransferases 7%
43. Catalytic Domain 7%
44. Vertebrates 7%
45. Cell Cycle 6%
46. Cellular Reprogramming 6%
47. Co-Repressor Proteins 6%
48. Hematopoietic Stem Cells 5%
49. Immediate-Early Genes 5%
50. Apoptosis 5%